ScholarIQanswers from OpenAlex

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model

PaperCitations, authors & open-access status

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model have?

ScholarIQcitation count

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model has 121 citations in the OpenAlex counts ScholarIQ stores.

When was Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model published?

ScholarIQyear

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model has 2012 year in the ScholarIQ index.

What is the open-access status of Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

ScholarIQoa status

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model has bronze oa status in the ScholarIQ index.

What is the DOI of Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

ScholarIQdoi

The DOI for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is on the source record.

What is the PMID of Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

ScholarIQpmid

The PMID for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is on the source record.

What is the OpenAlex record for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model?

ScholarIQopenalex

The OpenAlex for Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial